{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-093565","form_type":"8-K","ticker":"PHGE","cik":"0001739174","company_name":"BiomX Inc.","filed_at":"2026-08-25T21:00:14+00:00","discovered_at":"2026-08-25T21:01:05.445569+00:00","generated_at":"2026-08-25T21:01:17.486465+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BiomX shareholders approve Dr. Frucht issuance, reverse split, auditor ratification","bullets":["Approved issuance of shares to Mandragola Ltd. for Dr. Frucht Systems acquisition: 9,313,228 for, 429,645 against.","Approved reverse stock split of 1-for-5 to 1-for-20; authorized shares cut from 750M to 150M.","Ratified Barzily & Co. as independent auditor for FY2026: 9,575,900 for.","Quorum reached with 9,813,430 shares (36.9% of 26,559,607 outstanding); adjournment not needed."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-093565","json":"https://secwatch.observer/filing/0001213900-26-093565.json","markdown":"https://secwatch.observer/filing/0001213900-26-093565.md","text":"https://secwatch.observer/filing/0001213900-26-093565.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026093565/0001213900-26-093565-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026093565/ea0303308-8k_biomx.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-25T21:01:17.486465+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}